Predictors and impact of postoperative atrial fibrillation following thoracic surgery: a state-of-the-art review

Anaesthesia. 2023 Apr;78(4):491-500. doi: 10.1111/anae.15957. Epub 2023 Jan 11.

Abstract

This review of 19 studies (39,783 patients) of atrial fibrillation after thoracic surgery addresses the pathophysiology, incidence, and consequences of atrial fibrillation in this population, as well as its prevention and management. Interestingly, atrial fibrillation was most often identified in patients not previously known to have the disease. Rhythm control with amiodarone was the most commonly used treatment and nearly all patients were discharged in sinus rhythm. Major predictors were age; male sex; history of atrial fibrillation; congestive heart failure; left atrial enlargement; elevated brain natriuretic peptide level; and the invasiveness of procedures. Overall, patients with atrial fibrillation stayed 3 days longer in hospital. We also discuss the importance of standardising research on this subject and provide recommendations that might mitigate the impact postoperative atrial fibrillation on hospital resources.

Keywords: atrial fibrillation; health economics; healthcare costs; length of stay; thoracic surgery.

Publication types

  • Review

MeSH terms

  • Amiodarone*
  • Anti-Arrhythmia Agents / therapeutic use
  • Atrial Fibrillation* / epidemiology
  • Atrial Fibrillation* / etiology
  • Humans
  • Male
  • Thoracic Surgery*
  • Thoracic Surgical Procedures* / adverse effects

Substances

  • Anti-Arrhythmia Agents
  • Amiodarone